FDA takes steps to authorize some naloxone products for over-the-counter sale
FDA takes steps to authorize some overdose-reversing medicines for over-the-counter sale
Nov 15, 2022 by CBS News
Key Facts
- Food and Drug Administration has issued a notice that could help increase access to overdose-reversing naloxone drug products without the need for a prescription, paving the way to make more of them available for over-the-counter use.
- The notice issued by the FDA, known as a Federal Register notice, aims to change some naloxone drug products from prescription status to nonprescription status, in addition to developing and approving new products.
- The final decision will be made by the FDA, based on additional data that would usually be submitted to the agency in an application for a proposed nonprescription naloxone product.
- In addition to the FDA's push to make naloxone more accessible nationwide, the CDC has spoken in support of testing strips, a harm reduction tool that lets people who use drugs check for the presence of fentanyl in their substances.
GEOGRAPHY
ORGANIZATION
PERSON
GROUP
MISCELLANEOUS
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?